4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-024201
Director sold 60,000 shares at an average $92.51 ($5,550,644)
- Director acquired 60,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2020-09-01 | Option exercise | +30,000 | $14.00 | $420,000 | 30,000 | I |
| Bolzon Bradley J PhD Director | 2020-09-01 | Option exercise | +15,000 | $13.62 | $204,300 | 45,000 | I |
| Bolzon Bradley J PhD Director | 2020-09-01 | Option exercise | +15,000 | $59.31 | $889,650 | 60,000 | I |
| Bolzon Bradley J PhD Director | 2020-09-01 | Sale | −4,300 | $91.27 | $392,477 | 55,700 | I |
| Bolzon Bradley J PhD Director | 2020-09-01 | Sale | −36,365 | $92.40 | $3,360,162 | 19,335 | I |
| Bolzon Bradley J PhD Director | 2020-09-01 | Sale | −19,135 | $92.98 | $1,779,256 | 200 | I |
| Bolzon Bradley J PhD Director | 2020-09-01 | Sale | −200 | $93.74 | $18,748 | 0 | I |
| Derivatives | |||||||
| Bolzon Bradley J PhD Director | 2020-09-01 | Option exercise · Stock Option (Right to Buy) | −30,000 | 30,000 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-01 | Option exercise · Stock Option (Right to Buy) | −15,000 | 15,000 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-01 | Option exercise · Stock Option (Right to Buy) | −15,000 | 15,000 | I | ||
| Open-market sales · 60,000 sh · avg $92.51 · $5,550,644 | |||||||
Loading xslF345X03/doc4.xml…